Representing and advising Pharmadule OÜ’s management board at the management buyout transaction wherein the members of the management board acquired the Estonian company from the Scandinavian company which was a leader of delivering modular pharma and biopharma facilities.
Advising Pharmadule OÜ and its majority shareholder in a transaction for raising additional capital, including drafting and negotiating a shareholders’ agreement and redesigning the corporate structure. The capital was raised by Telstar SA, who became a strategic partner and co-owner of Pharmadule OÜ.
Telstar SA is an international leader in the development of integrated high-technology solutions in the process field for the pharmaceutical and biopharmaceutical industries.
Pharmadule OÜ is specialized in manufacturing modules for different industries such as pharma, biopharma and construction industries.